Skip to content
Film Television Auditions – Lifestyle
Author:
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
November 16, 2026
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
September 1, 2026
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
August 12, 2026
CNS Pharmaceuticals CFO, Steve O’Loughlin, Highlights Company’s Recent $22.5M Financing in Virtual Investor “What This Means” Segment
June 8, 2026
CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company’s Recent Strategic Transformation Progress
May 20, 2026